Science
Mechanism of Action
Functioning as a potent cellular signaling molecule, this fusion peptide primarily acts via the Epidermal Growth Factor (EGF) pathway. It specifically binds to Epidermal Growth Factor Receptors (EGFRs), initiating a cascade that stimulates cell growth, proliferation, and differentiation. This leads to enhanced skin repair through accelerated self-regeneration, improved blood vessel formation, and the release of key rejuvenating factors, promoting healing with minimal scarring. Additionally, it boosts the proliferation of essential skin cells like keratinocytes, endothelial cells, and fibroblasts, fortifying the skin barrier, mitigating inflammation, and reducing scar formation. This process also stimulates the synthesis of vital extracellular matrix components, including collagen, elastin, and hyaluronic acid, resulting in enhanced skin hydration, elasticity, and a visible reduction in fine lines and wrinkles.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Maintaining the biological activity of this fusion peptide, particularly its growth factor components, presents formulation challenges. While specific stability data for the complete blend is unavailable, insights from SH-Oligopeptide-1 suggest that low-temperature storage and transport may be necessary to preserve activity in some forms. For optimal stability during product development, it is generally advised to incorporate this ingredient in the final formulation phase, ensuring temperatures remain below 45℃.
Safety
Safety Profile
While SH-Oligopeptide-1, a key constituent, is naturally occurring and broadly deemed safe for cosmetic applications with existing safety data, critical considerations exist. As a growth factor, its potential to induce tumorigenesis if overexpressed or dysregulated is a concern, given its role in various tumor cell signaling pathways. Therefore, careful consideration and caution are advised for individuals with a history or predisposition to skin cancer. Although SH-Oligopeptide-1 is authorized for cosmetic use at varying concentrations, its long-term safety profile remains largely unexplored. Furthermore, the overall safety of this specific multi-peptide fusion blend has not undergone independent review by regulatory bodies such as CIR or SCCS.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While theoretically offering significant regenerative and anti-aging benefits, the lack of independent safety reviews for this specific fusion peptide blend, coupled with the potential tumorigenic concerns associated with growth factors, necessitates a cautious and critically evaluated approach to its use.
Related
Similar Ingredients
Finding similar ingredients…